Simulations Plus, Inc.

NASDAQ:SLP

Medical - Healthcare Information Services

Healthcare
$18.50 +0.11%

+$0.02 today

Market cap
$374.16M
Beta
1.32
P/E (TTM)
-5.9
EPS (TTM)
-$3.12
52W Low $11.09High $21.01

Volume 0.00M

Average 0.35M

SLP Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

Simulations Plus, Inc.NASDAQ: SLP

Gross Margin · Q2 FY2026 · quarter ended Feb 2026

Gross margin widens to 66.5%

Gross margin was 66.5% in Q2 FY2026, up 7.9 pp from a year earlier. On a trailing-twelve-month basis it was 62.0%, up 6.7 pp year over year. Over 3 fiscal years it narrowed by 21.5 pp.

Context

  • Gross margin widened in 1 of the last 3 fiscal years.
  • FY2025 was the lowest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterFeb 2026
66.5%+7.3 pp QoQ
Last fiscal yearAug 2025
58.4%-3.3 pp YoY
LTMFeb 2026
62.0%+6.7 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+7.9 pp——
1 year-3.3 pp——
3 years-21.5 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
58.4%
Year-over-year change
-3.3pp

Gross Margin vs competitors

How SLP compares with its peers on the latest reported figures

  • SLP's LTM Feb 2026 gross margin of 62.0% is the 7th highest of the 10 companies compared; the peer median is 69.0%.
  • Its year-over-year change of +6.7 pp is the highest of 10, against a peer median of -2.4 pp.
  • Over three fiscal years its change of -21.5 pp compares with a peer median of -4.4 pp.
SLP Competitors Peer median
Gross Margin for SLP and competitors
Company Period LTM level YoY 3-year change
ACIUAC Immune S.A.LTM Mar 2026100.0% +0.0 pp+0.0 pp
CLLSCellectis S.A.LTM Mar 202681.9% +0.5 pp+30.8 pp
KRROKorro Bio, Inc.LTM Mar 202673.2% -26.8 pp—
DHDefinitive Healthcare Corp.LTM Mar 202672.5% -4.4 pp-5.0 pp
OPRXOptimizeRx CorporationLTM Mar 202669.0% +4.9 pp+0.9 pp
SOPHSOPHiA GENETICS S.A.LTM Mar 202667.3% -0.8 pp-3.8 pp
SLPSimulations Plus, Inc.LTM Feb 202662.0% +6.7 pp-21.5 pp
NRCNational Research CorporationLTM Mar 202655.9% -3.3 pp-6.0 pp
AGLAgilon Health, Inc.LTM Mar 2026-2.7% -2.4 pp-7.8 pp
NAKANakamoto Inc.LTM Mar 2026-376.0% -309.7 pp-604.8 pp
ANROAlto Neuroscience, Inc.FY2025— ——
Peer median (excluding SLP) 69.0%-2.4 pp-4.4 pp

Competitors are the stored peer set for SLP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Aug 2021
FY2022
Aug 2022
FY2023
Aug 2023
FY2024
Aug 2024
FY2025
Aug 2025
Revenue46.47M53.91M59.58M70.01M79.18M
Cost of Revenue10.6M10.82M11.63M26.86M32.96M
Gross Profit35.87M43.08M47.95M43.15M46.22M
Gross Margin77.2%79.9%80.5%61.6%58.4%
Research & Development4.05M3.21M4.5M5.75M6.88M
Selling, General & Admin20.57M24.97M34.72M31.27M32.85M
Operating Expenses24.61M28.17M39.22M37.02M116.95M
Depreciation & Amortization3.59M3.57M3.84M5.67M8.21M
EBITDA14.7M18.69M13.07M18.08M14.7M
EBITDA Margin31.6%34.7%21.9%25.8%18.6%
Operating Income11.25M14.91M8.73M6.13M(70.73M)
Operating Margin24.2%27.7%14.6%8.8%-89.3%
Interest Income201K717K4.13M4.38M722K
Interest Expense22K0000
Other Income / Expenses(168K)204K2.97M6.28M1.35M
Income Before Tax11.09M15.12M11.7M12.41M(69.38M)
Pre-Tax Margin23.9%28.0%19.6%17.7%-87.6%
Income Tax Expense1.3M2.63M1.73M2.46M(4.66M)
Net Income9.78M12.48M9.96M9.95M(64.72M)
Net Margin21.1%23.2%16.7%14.2%-81.7%
EPS (Basic)0.490.620.500.50(3.22)
EPS (Diluted)0.470.600.490.49(3.22)
Weighted Avg Shares20.05M20.2M20.08M19.99M20.1M
Weighted Avg Shares (Diluted)20.74M20.75M20.47M20.3M20.1M

Simulations Plus, Inc.

NASDAQ:SLP

Intrinsic Alpha fair value

Locked

Current Price

$18.50

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.